by Dr. David Velkoff on July 10th, 2010

For 30 years the Drake Institute has made neurofeedback and biofeedback the centerpiece of its treatment programs. It gives us a method to access brain functioning without any negative side effects and restore normalcy, thereby reducing or eliminating symptoms. It is not an "add on" to other therapies or medications in the Institute's treatment programs. . It is the central treatment though we may provide adjunctive counseling or treatment of learning disorders secondarily.  Because it has been the central treatment for our patients for 30 years, it has enabled the Drake Institute to develop leading edge knowledge and clinical experience in its applications for ADHD

By Art Harris- (Emmy award winning journalist, formerly of CNN and the Washington Post)

LOS ANGELES, CA. – She was a mother without hope. Diagnosed with autism, her six year old son, EJ, bit other children, threw tantrums and chairs. “He had no future,” says Beatrice Tan, whose family stopped going to church--too risky to put EJ in the nursery.

Now, after several months of specialized Neurofeedback therapy at Drake Institute of Behavioral Medicine in Los Angeles, EJ no longer bites: he hugs. He has friends, and “we have hope,” says Beatrice, now back in church with EJ and husband, Ronnie.

NIJMEGEN, The Netherlands, July 16 /PRNewswire/ -- Neurofeedback - also called EEG Biofeedback - is a method used to train brain activity in order to normalize Brain function and treat psychiatric disorders. This treatment method has gained interest over the last 10 years, however the question whether this treatment should be regarded as an Evidence-Based treatment was unanswered until now. Tomorrow a study will be published in the scientific journal 'EEG and Clinical Neuroscience' demonstrating that Neurofeedback can indeed be regarded as an evidence-based treatment for Attention Deficit- / Hyperactivity Disorder (ADHD).

By SHANKAR VEDANTAM - The Washington Post - Friday, March 27, 2009

WASHINGTON -- New data from a large federal study have reignited a debate over the effectiveness of long-term drug treatment of children with hyperactivity or attention-deficit disorder, and have drawn accusations that some members of the research team have sought to play down evidence that medications do little good beyond 24 months.

The study also indicated that long-term use of the drugs can stunt children's growth. The latest data paint a very different picture than the study's positive initial results, reported in 1999.

FDA Examines Incidence of Psychotic Symptoms in Children Taking ADHD Medications

By Salynn Boyles WebMD Health News Reviewed by Louise Chang, MD

Jan. 26, 2009 -- Treatment-related hallucinations and other psychotic symptoms in children with attention deficit hyperactivity disorder (ADHD) may be more common than previously thought, FDA officials report in the latest issue of the journal Pediatrics.